Table 2 Univariate and multivariate Cox proportional hazards model results
From: Serum gamma-glutamyltransferase and the overall survival of metastatic pancreatic cancer
Covariates | Univariate Cox model | Multivariate Cox model | ||
|---|---|---|---|---|
Crude HR (95% CI) | p value | Adjusted HR (95% CI) | p value | |
Age at diagnosis (+ 5 years) | 1.10 (1.03, 1.16) | 10–2.9 | 1.08 (1.01, 1.15) | 10–1.7 |
Sex (Male) | 1.02 (0.81, 1.29) | 0.87 | ||
Palliative chemotherapy (Yes) | 0.69 (0.54, 0.87) | 10–2.9 | 0.81 (0.62, 1.04) | 0.10 |
Baseline serum ALB (< 35 g/L) | 1.25 (0.98, 1.59) | 0.10 | ||
Baseline serum TBIL (> 20.5 μmol/L) | 1.19 (0.93, 1.50) | 0.16 | ||
Baseline serum ALT (> 60 U/L) | 1.17 (0.91, 1.50) | 0.22 | ||
Baseline serum NLR (+ 10) | 1.10 (0.97, 1.25) | 0.15 | ||
Baseline FPG (≥7.0 mmol/L) | 1.32 (1.04, 1.68) | 10–1.7 | 1.39 (1.08, 1.79) | 10–2.0 |
Baseline serum GGT (> 48 U/L) | 1.78 (1.40, 2.26) | 10–6.0 | 1.53 (1.19, 1.97) | 10–3.2 |